These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28237400)

  • 1. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
    Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
    Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
    Prabhu RS; Press RH; Boselli DM; Miller KR; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Burri SH
    J Neurooncol; 2018 Mar; 137(1):147-154. PubMed ID: 29218431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer.
    Crouzen JA; Mast ME; Hakstege M; Broekman MLD; Baladi C; Mertens BJA; Nandoe Tewarie RDS; Kerkhof M; Vos MJ; Maas KW; Souwer ETD; Wiggenraad RGJ; van der Voort van Zyp NCMG; Kiderlen M; Petoukhova AL; Zindler JD
    Radiother Oncol; 2024 Sep; 198():110405. PubMed ID: 38925263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
    Aoyama H; Tago M; Shirato H;
    JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
    Louie AV; Haasbeek CJ; Mokhles S; Rodrigues GB; Stephans KL; Lagerwaard FJ; Palma DA; Videtic GM; Warner A; Takkenberg JJ; Reddy CA; Maat AP; Woody NM; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):82-90. PubMed ID: 26138912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer.
    Kakusa B; Han S; Aggarwal S; Liu B; Li G; Soltys S; Hayden Gephart M
    J Neurooncol; 2018 Dec; 140(3):705-715. PubMed ID: 30460628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
    Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
    Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
    Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
    J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms.
    Nieder C; Mehta MP; Geinitz H; Grosu AL
    Crit Rev Oncol Hematol; 2018 Jun; 126():13-18. PubMed ID: 29759555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
    Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M
    Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery.
    Zindler JD; Rodrigues G; Haasbeek CJ; De Haan PF; Meijer OW; Slotman BJ; Lagerwaard FJ
    Radiother Oncol; 2013 Mar; 106(3):370-4. PubMed ID: 23522151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
    Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
    Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.
    Tanadini-Lang S; Rieber J; Filippi AR; Fode MM; Streblow J; Adebahr S; Andratschke N; Blanck O; Boda-Heggemann J; Duma M; Eble MJ; Ernst I; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lohaus F; Petersen C; Schrade E; Wendt TG; Wittig A; Høyer M; Ricardi U; Sterzing F; Guckenberger M
    Radiother Oncol; 2017 May; 123(2):182-188. PubMed ID: 28169042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.
    Chiang CL; Yang HC; Luo YH; Chen CJ; Wu HM; Chen YM; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Chou TY; Pan DH; Lee CC
    J Neurosurg; 2023 Aug; 139(2):385-392. PubMed ID: 36681978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma.
    Duijm M; Oomen-de Hoop E; van Voort van der Zyp N; van de Vaart P; Tekatli H; Hoogeman M; Senan S; Nuyttens J
    Radiother Oncol; 2021 Mar; 156():223-230. PubMed ID: 33418006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.
    Ayala-Peacock DN; Attia A; Braunstein SE; Ahluwalia MS; Hepel J; Chung C; Contessa J; McTyre E; Peiffer AM; Lucas JT; Isom S; Pajewski NM; Kotecha R; Stavas MJ; Page BR; Kleinberg L; Shen C; Taylor RB; Onyeuku NE; Hyde AT; Gorovets D; Chao ST; Corso C; Ruiz J; Watabe K; Tatter SB; Zadeh G; Chiang VLS; Fiveash JB; Chan MD
    J Neurooncol; 2017 Nov; 135(2):403-411. PubMed ID: 28828698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.